Literature DB >> 24861661

Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients.

L Brusa1, S Musco2, G Bernardi3, C Iani4, M Pierantozzi3, P Stanzione3, A Stefani3, E Finazzi Agro'5.   

Abstract

Entities:  

Keywords:  Bladder; Dopamine; Parkinson; Rasagiline

Mesh：

Substances：

Year:  2014        PMID： 24861661     DOI： 10.1016/j.parkreldis.2014.04.020

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  6 in total

Review 1.  Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.

Authors:  Ryuji Sakakibara; Fuyuki Tateno; Tatsuya Yamamoto; Tomoyuki Uchiyama; Tomonori Yamanishi
Journal:  Clin Auton Res       Date:  2017-11-09       Impact factor: 4.435

2.  Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson's disease: A systematic review.

Authors:  Takashi Tsuboi; Yuki Satake; Keita Hiraga; Katsunori Yokoi; Makoto Hattori; Masashi Suzuki; Kazuhiro Hara; Adolfo Ramirez-Zamora; Michael S Okun; Masahisa Katsuno
Journal:  NPJ Parkinsons Dis       Date:  2022-06-13

Review 3.  The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice.

Authors:  Giuseppe Loddo; Giovanna Calandra-Buonaura; Luisa Sambati; Giulia Giannini; Annagrazia Cecere; Pietro Cortelli; Federica Provini
Journal:  Front Neurol       Date:  2017-02-16       Impact factor: 4.003

4.  SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease.

Authors:  Ana Gómez-López; Arantxa Sánchez-Sánchez; Elena Natera-Villalba; Victoria Ros-Castelló; Álvaro Beltrán-Corbellini; Samira Fanjul-Arbós; Isabel Pareés Moreno; José Luis López-Sendon Moreno; Juan Carlos Martínez Castrillo; Araceli Alonso-Canovas
Journal:  Brain Sci       Date:  2021-01-06

Review 5.  The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.

Authors:  Zanna J Voysey; Roger A Barker; Alpar S Lazar
Journal:  Neurotherapeutics       Date:  2020-11-11       Impact factor: 7.620

Review 6.  Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future.

Authors:  Yu-Yan Tan; Peter Jenner; Sheng-Di Chen
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.